Patents by Inventor Kevin Mrohs

Kevin Mrohs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for treating skin conditions
    Patent number: 10751297
    Abstract: Provided herein are compositions and related methods for the treatment of herpes simplex virus (HSV) induced blisters and resulting ulcerative lesions. The composition includes at least one antiviral agent that is a long-chain aliphatic compound, and at least one topical corticosteroid.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: August 25, 2020
    Inventor: Kevin Mrohs
  • Composition and method for treating skin conditions
    Patent number: 10543177
    Abstract: Provided herein are compositions and related methods for the treatment of herpes simplex virus (HSV) induced blisters and resulting ulcerative lesions. The composition includes at least one antiviral agent that is a long-chain aliphatic compound, and at least one topical corticosteroid.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: January 28, 2020
    Inventor: Kevin Mrohs
  • COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
    Publication number: 20190336455
    Abstract: Provided herein are compositions and related methods for the treatment of herpes simplex virus (HSV) induced blisters and resulting ulcerative lesions. The composition includes at least one antiviral agent that is a long-chain aliphatic compound, and at least one topical corticosteroid.
    Type: Application
    Filed: July 19, 2019
    Publication date: November 7, 2019
    Inventor: Kevin Mrohs
  • COMPOSITION AND METHOD FOR TREATING SKIN CONDITIONS
    Publication number: 20180289633
    Abstract: Provided herein are compositions and related methods for the treatment of herpes simplex virus (HSV) induced blisters and resulting ulcerative lesions. The composition includes at least one antiviral agent that is a long-chain aliphatic compound, and at least one topical corticosteroid.
    Type: Application
    Filed: November 30, 2017
    Publication date: October 11, 2018
    Inventor: Kevin Mrohs